Länder Analysen: Großbritannien
| 06.08.25 | Diageo Buy | UBS AG | |
| 06.08.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 05.08.25 | Linde Buy | Jefferies & Company Inc. | |
| 05.08.25 | BP Kaufen | DZ BANK | |
| 05.08.25 | Diageo Outperform | Bernstein Research | |
| 05.08.25 | Diageo Buy | UBS AG | |
| 05.08.25 | AstraZeneca Buy | UBS AG | |
| 05.08.25 | BAT Buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 04.08.25 | Linde Overweight | JP Morgan Chase & Co. | |
| 04.08.25 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.08.25 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 04.08.25 | Linde Outperform | Bernstein Research | |
| 04.08.25 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.08.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.08.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 01.08.25 | GSK Outperform | Bernstein Research | |
| 01.08.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.08.25 | Linde Outperform | Bernstein Research | |
| 01.08.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 01.08.25 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 01.08.25 | BAT Buy | Deutsche Bank AG | |
| 01.08.25 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 31.07.25 | Unilever Buy | Deutsche Bank AG | |
| 31.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Diageo Buy | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Buy | Jefferies & Company Inc. | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Diageo Outperform | Bernstein Research | |
| 28.07.25 | National Grid Buy | Jefferies & Company Inc. | |
| 28.07.25 | GSK Outperform | Bernstein Research | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 28.07.25 | London Stock Exchange (LSE) Buy | UBS AG | |
| 25.07.25 | Rolls-Royce Buy | Deutsche Bank AG | |
| 25.07.25 | RELX Overweight | Barclays Capital | |
| 25.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | Reckitt Benckiser Outperform | Bernstein Research | |
| 23.07.25 | Rio Tinto Buy | Deutsche Bank AG | |
| 23.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 22.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | National Grid Overweight | Barclays Capital | |
| 21.07.25 | Linde Outperform | RBC Capital Markets | |